Due to the rarity of the disease, data are lacking on the relationships between AML and most risk factors, and strong connections have not been made through epidemiological studies.

Pleco Therapeutics is proud to be focusing on a disease where drug development is highly needed.

Leave a Reply

Your email address will not be published. Required fields are marked *